학술논문
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12
Document Type
Article
Author
Source
In Gynecologic Oncology February 2019 152(2):235-242
Subject
Language
ISSN
0090-8258